---
$id: https://graph.org.ai/products/commodity/51111844
$type: Product
source: UNSPSC
code: "51111844"
title: "Fadrozole"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fadrozole

**UNSPSC Code**: 51111844
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C14H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H3988M64PU, chemically known as benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)- but generally known as fadrozole, which bears US NIH Compound Identifier 59693. European Medicines Agency schedules Fadrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07497MIG. The term FADROZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). FADROZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fadrozole under HS 29339990 and SITC 51577. As of Q4 2014, FADROZOLE remains the US FDA Preferred Term for this commodity. Fadrozole bears US NLM identifiers UMLS ID C0117234 and NCI Concept Code C79911. SMILES: N12C(CCCC1CNC2)C1CCC(CC1)C#N.

